AbVitro

AbVitro, a spinout from George Church’s lab at Harvard University

At AbVitro, they are committed to advancing the treatment of poorly understood human diseases with an underlying immune component. Their mission is to harness the power of the human immune system and its role in complex diseases to uncover new potential therapeutic targets or biomarkers, while simultaneously discovering and evaluating their respective fully human antibody binders for therapeutic potential. Simply put, They find new therapeutic targets with matching therapeutic antibodies and/or T cell receptors (TCRs) in diseases with unmet medical needs.